article thumbnail

Off-Label Semaglutide Linked to Deaths, Hospitalizations Calling for Compounding Regulation

Pharmacy Times

Off-label semaglutide has been linked to serious adverse effects, calling for increased regulation around compounding.

article thumbnail

FDA issues warnings to GLP-1 compounders

The Checkup by Singlecare

As a result, the use of medications like Ozempic , Wegovy , Zepbound , Rybelsus , and Mounjaro has skyrocketed, as people turned to these medications to help them lose weightcausing drug shortages and creating a market for compounded versions of these brand-name drugs. RELATED: Is compounded semaglutide safe? But the U.S.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

STAT+: Pharmalittle: We’re watching a ban compounded versions of GLP-1s, a Biogen acquisition, and more

STAT

A drug often used off-label to treat alcohol use disorder might provide better benefits than therapies approved for this indication, STAT tells us. Australia to ban compounded versions of blockbuster drugs Ozempic and Mounjaro, Reuters reports. If you don’t believe me, just read these items.

article thumbnail

Noom to offer compounded GLP-1 drug to rival pricey branded weight loss meds

Fierce Healthcare

Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers. Noom is the latest digital health company to jump into the off-label weight loss drug market to make medications more accessible to consumers.

article thumbnail

Is compounded semaglutide safe?

The Checkup by Singlecare

Semaglutide has become a very popular drug thats in high demand in pharmacies everywhere and is currently also available from compounding pharmacies and online. But not all compounded semaglutide products are safe. Heres what to know about buying semaglutide from a compounded pharmacy or online. What is compounded semaglutide?

article thumbnail

Weight loss drugs without a prescription? Study warns it’s a ‘very risky business’

STAT

In the face of ongoing shortages of the obesity and diabetes medications known as GLP-1s, patients have resorted to a wide array of sources for the drugs, including medical spas and telehealth sites that prescribe compounded versions of the drugs. One sample also contained signs of potential bacterial contamination during manufacturing.

article thumbnail

Europe’s pharmaceutical packaging market to value over $35bn by 2028

European Pharmaceutical Review

Europe’s pharmaceutical packaging and labelling market is projected to reach $35.78 billion in 2022, the pharmaceutical packaging and labelling market in Europe is expected to expand at a compound annual growth rate (CAGR) of 4.78 This is projected to grow at the highest compound annual growth rate of 5.27

Packaging 118